KMI
67
-2
MCD
52
2
TXT
55
3
IBM
58
-2
PNC
64
4
COF
60
2
DVN
21
3
EMN
60
4
MA
64
7
HON
67
2
CAH
48
-5
AON
54
2
FTI
81
5
R
71
4
HCP
66
8
NVDA
56
-4
ROP
62
3
URBN
56
14
RIG
60
2
SIG
52
3
KMI
67
-2
MCD
52
2
TXT
55
3
IBM
58
-2
PNC
64
4
COF
60
2
DVN
21
3
EMN
60
4
MA
64
7
HON
67
2
CAH
48
-5
AON
54
2
FTI
81
5
R
71
4
HCP
66
8
NVDA
56
-4
ROP
62
3
URBN
56
14
RIG
60
2
SIG
52
3
Financhill
Back

T2 Biosystems Vs. Perspective Therapeutics Industry Stock Comparison

Sell
5

TTOO
T2 Biosystems

Last Price:
0.51
Seasonality Move:
5.81%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.49
Seasonality Move:
34.33%
Sell
5
T2 Biosystems (TTOO) is a Sell

Is T2 Biosystems a Buy, Sell or Hold?

  • The current T2 Biosystems [TTOO] share price is $0.51. The Score for TTOO is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
  • TTOO is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.47. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TTOO Stock Price Chart

What is T2 Biosystems's stock price today?

  • The T2 Biosystems share price today is $0.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TTOO is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

TTOO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 24.94 Sell
Chaikin Money Flow: 2066461 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.47 - 1.13) Sell
Bollinger Bands (100): (1.12 - 4.34) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.06 Sell
Relative Strength Index (14 RSI): 14.31 Sell
Chaikin Money Flow: 5909257 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.39 - 12.93) Sell
Bollinger Bands (100): (10.25 - 14.79) Sell

TTOO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.49 Buy
20-day SMA: 0.67 Sell
50-day SMA: 1.33 Sell
200-day SMA: 3.55 Sell
8-day EMA: 0.51 Sell
20-day EMA: 0.72 Sell
50-day EMA: 1.38 Sell
200-day EMA: 13.03 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.64 Sell
20-day SMA: 9.7 Sell
50-day SMA: 11.58 Sell
200-day SMA: 12.72 Sell
8-day EMA: 6.25 Sell
20-day EMA: 8.74 Sell
50-day EMA: 10.88 Sell
200-day EMA: 11.36 Sell

T2 Biosystems Earnings Growth & TTOO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.69 per share, a decrease next quarter of $0.00 per share, an increase this year of $20.64 per share, and an increase next year of $1.91 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

T2 Biosystems Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):